Literature DB >> 24145049

Afferent and efferent immunological pathways of the brain. Anatomy, function and failure.

R O Carare1, C A Hawkes2, R O Weller2.   

Abstract

Immunological privilege appears to be a product of unique lymphatic drainage systems for the brain and receptor-mediated entry of inflammatory cells through the blood-brain barrier. Most organs of the body have well-defined lymphatic vessels that carry extracellular fluid, antigen presenting cells, lymphocytes, neoplastic cells and even bacteria to regional lymph nodes. The brain has no such conventional lymphatics, but has perivascular pathways that drain interstitial fluid (ISF) from brain parenchyma and cerebrospinal fluid (CSF) from the subarachnoid space to cervical lymph nodes. ISF and solutes drain along narrow, ∼100 nm-thick basement membranes within the walls of cerebral capillaries and arteries to cervical lymph nodes; this pathway does not allow traffic of lymphocytes or antigen presenting cells from brain to lymph nodes. Although CSF drains into blood through arachnoid villi, CSF also drains from the subarachnoid space through channels in the cribriform plate of the ethmoid bone into nasal lymphatics and thence to cervical lymph nodes. This pathway does allow the traffic of lymphocytes and antigen presenting cells from CSF to cervical lymph nodes. Efferent pathways by which lymphocytes enter the brain are regulated by selected integrins on lymphocytes and selective receptors on vascular endothelial cells. Here we review: (1) the structure and function of afferent lymphatic drainage of ISF and CSF, (2) mechanisms involved in the efferent pathways by which lymphocytes enter the brain and (3) the failure of lymphatic drainage of the brain parenchyma with age and the role of such failure in the pathogenesis of Alzheimer's disease. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; BM; Blood–brain barrier; Brain; CSF; IC; Interstitial fluid; Lymphatic drainage; Neuroimmunology; SMC; basement membrane (green contains tracer); immune complexes derived from the blood and entrapped in basement membranes of the perivascular drainage pathways; smooth muscle cell in the tunica media of the artery

Mesh:

Year:  2013        PMID: 24145049     DOI: 10.1016/j.bbi.2013.10.012

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  40 in total

Review 1.  Vaccination in the immunotherapy of glioblastoma.

Authors:  Ziren Kong; Yu Wang; Wenbin Ma
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

Review 2.  The movers and shapers in immune privilege of the CNS.

Authors:  Britta Engelhardt; Peter Vajkoczy; Roy O Weller
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 3.  Pathogenesis of cerebral palsy through the prism of immune regulation of nervous tissue homeostasis: literature review.

Authors:  Natalya Lisovska; Zholtay Daribayev; Yevgeny Lisovskyy; Kenzhe Kussainova; Lana Austin; Sholpan Bulekbayeva
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

Review 4.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

5.  High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs.

Authors:  J Pleticha; S A Malkmus; L F Heilmann; S L Veesart; R Rezek; Q Xu; T L Yaksh; A S Beutler
Journal:  Gene Ther       Date:  2014-10-30       Impact factor: 5.250

Review 6.  Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2017-07-15       Impact factor: 3.969

Review 7.  Getting nervous about immunity.

Authors:  Keith W Kelley; Robert H McCusker
Journal:  Semin Immunol       Date:  2014-02-18       Impact factor: 11.130

Review 8.  Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2018-10-19

Review 9.  The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.

Authors:  P R Lowenstein; M G Castro
Journal:  Adv Pharmacol       Date:  2016-04-23

Review 10.  Antigen Presentation After Stroke.

Authors:  Francesc Miró-Mur; Xabier Urra; Mattia Gallizioli; Angel Chamorro; Anna M Planas
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.